Evaluating the impact of technology in radiotherapy for cancer patients
Official title: Partnership Initiative for the Evaluation of Technological Innovation in Radiotherapy
Run by Centre hospitalier de l'Université de Montréal (CHUM) · NCT03378856 · Data updated 2026-11-12
This study is trying to see how technology in radiotherapy affects cancer patients by collecting their health information and experiences during treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | Centre hospitalier de l'Université de Montréal (CHUM) Academic / other |
| Drugs / interventions | radiation |
| Locations | 9 sites (Kelowna, British Columbia and 8 other locations) |
| Status | Recruiting |
| Started | November 1, 2017 |
| Main results expected | October 2040 |
| Study ends | October 2040 |
| Registry record updated | September 1, 2026 |
| Trial ID | NCT03378856 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients who are currently receiving radiotherapy or brachytherapy and can provide informed consent.
✕Probably not a fit
Patients who are not receiving radiotherapy or brachytherapy will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to establish a robust infrastructure for systematically collecting clinical data, patient-reported outcomes, and imaging data from patients undergoing standard-care radiotherapy. It focuses on understanding the effects of radiation and long-term outcomes by creating a prospective cohort of participants who consent to data collection. The study also allows for future randomized controlled trials (RCTs) within the cohort, enabling comparative effectiveness research and exploration of dose-effect relationships. By capturing patient-reported outcomes at baseline and during follow-up, the study seeks to enhance the understanding of radiotherapy's impact on patients.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding of radiotherapy effects, ultimately enhancing patient care and treatment outcomes.
How similar studies have gone: Other studies utilizing similar cohort designs and data collection methods have shown promise in improving patient outcomes and understanding treatment effects.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ability to provide informed consent * Receiving radiotherapy or brachytherapy Exclusion Criteria: \-
Where it's running
-
BC Cancer - Kelowna
Kelowna, British Columbia, Canada Recruiting -
BC Cancer - Vancouver
Vancouver, British Columbia, Canada Recruiting -
London Health Regional Cancer Centre
London, Ontario, Canada Recruiting -
Sunnybrook Research Institute
Toronto, Ontario, Canada Recruiting -
Princess Margaret Cancer Centre
Toronto, Ontario, Canada Recruiting -
CISSS de Laval - Hôpital de la Cité-de-la-Santé
Laval, Quebec, Canada Recruiting
Show 3 more locations
-
Research Institute of the McGill University Health Center
Montreal, Quebec, Canada Recruiting -
Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, Canada Recruiting -
CHU de Québec - Université Laval
Québec, Quebec, Canada Recruiting
Study contacts
- Study coordinator: Cynthia Ménard, MD, M.Sc
- Email: Cynthia.Menard@umontreal.ca
- Phone: 514-890-8254
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Self‑manual lymph drainage for head and neck lymphedema
This trial will test whether different intensities of self‑applied manual lymph drainage help people with head and neck lymphedema after radiotherapy for oropharyngeal cancer.
-
Health-Oriented Protocol for Epidermal Radiodermatitis
This study looks at how skin reactions from radiation therapy affect adults with head/neck or pelvic cancers and whether certain factors influence RID outcomes.
-
Skipping the clinical target volume (CTV) around the primary tumor in limited-stage small cell lung cancer
This trial tests whether giving chest radiotherapy that skips the usual extra margin around the main tumor is as effective and causes fewer side effects for people with limited-stage small cell lung cancer who have responded to initial chemotherapy.
-
Curative chest re‑irradiation for thoracic cancers
This project will try a standardized high‑dose re‑radiation approach for adults with recurrent or new thoracic cancers who previously received chest radiotherapy to see how well it controls disease and what toxicities occur.
-
Radiotherapy for Head and Neck Cancer with Simultaneous Integrated Boost
This study is testing a new type of radiation therapy for people with head and neck cancer to see if it helps them live longer and feel better while causing fewer side effects.
-
Comparing total neoadjuvant therapy with surgery for rectal cancer treatment
This study is testing if rectal cancer patients who respond well to a new treatment can skip surgery and just be monitored to see how they do compared to those who have surgery right away.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.